20 LATEST RESOURCES (205 INDEXED)
Mobile Health Applications for Postpartum Depression Management: A Theory-Informed Analysis of Change-Use-Engagement (CUE) Criteria in the Digital Environment (MEDINFO 2021: One World, One Health – Global Partnership for Digital Innovation) (Meetings-Events) · June 2022
Publications (Chapters)
IOS Press
Pharmacogenomic Testing in Depression: A 2021 Update · January 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Children and Mental Health: Preventive Approaches to Anxiety and Depression · October 2021
Publications (Books-Reports)
European Union
Targeting GABA Receptors to Treat Postpartum Depression (Novel Molecular Targets for Mood Disorders and Psychosis: Proceedings of a Workshop) (Meetings-Events) · August 2021
Publications (Chapters)
National Academies Press
Targeting Glutamate Receptors for Treatment-Resistant Depression (Novel Molecular Targets for Mood Disorders and Psychosis: Proceedings of a Workshop) (Meetings-Events) · August 2021
Publications (Chapters)
National Academies Press
School-Based Interventions to Prevent Anxiety, Depression and Conduct Disorder in Children and Young People: A Systematic Review and Network Meta-Analysis · August 2021
Publications (Books-Reports)
National Institute for Health Research
Screening for Antenatal Depression by Midwives in Low Resource Settings in Primary Care Settings in Malawi (Healthcare Access) · July 2021
Publications (Chapters)
IntechOpen Books
Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders · June 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Repetitive Transcranial Magnetic Stimulation for People with Treatment-Resistant Depression: A Health Technology Assessment · May 2021
Publications (Books-Reports)
NCBI>Ontario Health Technology Assessment Series
Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia) · April 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Bupropion for Treatment Resistant Depression · April 2021
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Clinical Interventions for Adults with Comorbid Alcohol Use and Depressive Disorders: A Systematic Review and Network Meta-Analysis · December 2020
Publications (Books-Reports)
RAND Corporation
The Outcome of Eating Disorders: Relapse, Childbirth, Postnatal Depression, Family Support (Psychology and Pathophysiological Outcomes of Eating) · December 2020
Publications (Chapters)
IntechOpen Books
Psychotherapy and Pharmacotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Rapid Qualitative Review · March 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Quetiapine for Major Depressive Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Pharmacogenomic Testing in Depression: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Neuropharmacology of Secondary Metabolites from Plants with Anxiolytic and Antidepressant Properties (Behavioral Pharmacology: From Basic to Clinical Research) · February 2020
Publications (Chapters)
IntechOpen Books
Cognitive Behavioral Therapy for Depression (Clinical Practice Guidelines) · January 2020
Publications (Guidelines)
Indian Journal of Psychiatry
Group Interpersonal Therapy (IPT) for Depression · January 2020
Publications (Books-Reports)
World Health Organization
Association of Vitamin D Deficiency and Mood Disorders: A Systematic Review (Vitamin D Deficiency) · December 2019
Publications (Chapters)
IntechOpen Books